chr16-27403184-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181079.5(IL21R):c.14G>A(p.Cys5Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,338,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 5/5 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_181079.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL21R | NM_181078.3 | c.-17+566G>A | intron_variant | ENST00000337929.8 | NP_851564.1 | |||
IL21R | NM_181079.5 | c.14G>A | p.Cys5Tyr | missense_variant | 2/10 | NP_851565.4 | ||
IL21R | XM_011545857.4 | c.14G>A | p.Cys5Tyr | missense_variant | 2/10 | XP_011544159.1 | ||
IL21R | XM_017023257.3 | c.-147+566G>A | intron_variant | XP_016878746.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL21R | ENST00000337929.8 | c.-17+566G>A | intron_variant | 1 | NM_181078.3 | ENSP00000338010.3 | ||||
IL21R | ENST00000564089 | c.-53G>A | 5_prime_UTR_variant | 2/10 | 5 | ENSP00000456707.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000520 AC: 7AN: 134614Hom.: 0 AF XY: 0.0000409 AC XY: 3AN XY: 73292
GnomAD4 exome AF: 0.0000396 AC: 47AN: 1186542Hom.: 0 Cov.: 28 AF XY: 0.0000327 AC XY: 19AN XY: 581142
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74360
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.14G>A (p.C5Y) alteration is located in exon 2 (coding exon 1) of the IL21R gene. This alteration results from a G to A substitution at nucleotide position 14, causing the cysteine (C) at amino acid position 5 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at